Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 6 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2347.06 | 578 / 578 | 98% | 10.58 | 1127 / 1155 |
breast | 100% | 1046.89 | 459 / 459 | 97% | 9.36 | 1082 / 1118 |
ovary | 100% | 1303.37 | 180 / 180 | 94% | 5.84 | 406 / 430 |
kidney | 100% | 791.56 | 89 / 89 | 93% | 13.61 | 840 / 901 |
uterus | 100% | 769.72 | 170 / 170 | 91% | 6.69 | 416 / 459 |
thymus | 99% | 705.61 | 645 / 653 | 92% | 7.98 | 554 / 605 |
esophagus | 92% | 419.62 | 1331 / 1445 | 86% | 5.05 | 157 / 183 |
adrenal gland | 97% | 508.45 | 251 / 258 | 80% | 4.28 | 184 / 230 |
prostate | 98% | 624.93 | 239 / 245 | 79% | 3.70 | 395 / 502 |
bladder | 90% | 639.52 | 19 / 21 | 81% | 5.65 | 408 / 504 |
stomach | 90% | 373.50 | 324 / 359 | 78% | 6.02 | 224 / 286 |
intestine | 90% | 985.78 | 870 / 966 | 73% | 5.26 | 387 / 527 |
liver | 87% | 355.53 | 197 / 226 | 68% | 3.72 | 277 / 406 |
skin | 65% | 300.50 | 1172 / 1809 | 84% | 10.42 | 397 / 472 |
brain | 50% | 182.66 | 1314 / 2642 | 96% | 8.22 | 676 / 705 |
pancreas | 20% | 62.72 | 67 / 328 | 94% | 8.56 | 168 / 178 |
adipose | 100% | 1245.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 114.02 | 29 / 29 |
spleen | 100% | 8499.23 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 9423.09 | 905 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 12.85 | 42 / 45 |
heart | 93% | 434.19 | 801 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 65% | 369.75 | 862 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 31% | 1.58 | 25 / 80 |
muscle | 30% | 83.95 | 243 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0051058 | Biological process | negative regulation of small GTPase mediated signal transduction |
GO_0007015 | Biological process | actin filament organization |
GO_0006911 | Biological process | phagocytosis, engulfment |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0001891 | Cellular component | phagocytic cup |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP25 |
Protein name | Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25) Epididymis secretory protein Li 308 (Rho GTPase activating protein 25, isoform CRA_b) ARHGAP25 Rho GTPase activating protein 25 |
Synonyms | KIAA0053 hCG_16854 HEL-S-308 |
Description | FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. . |
Accessions | ENST00000479844.1 ENST00000488795.1 ENST00000409202.8 [P42331-4] H7C4P1 P42331 ENST00000497079.5 [P42331-2] ENST00000473986.1 ENST00000497259.5 F8WAV9 F8WDF6 A0A2X0TVS2 V9HWC8 ENST00000409220.5 [P42331-6] ENST00000409030.7 [P42331-3] ENST00000467265.5 [P42331-5] C9JB56 |